NCT07467616Completed
Impact of Clinical Nursing Guideline on Outcomes of Children With Diabetic Ketoacidosis.
Impact of an Evidence-Based Practice Nursing Guideline on Clinical Outcomes in Children With Diabetic Ketoacidosis: A Quasi-Experimental Study
Source: ClinicalTrials.gov · Last updated 12 Mar 2026
Brief summary (registry, in English)
Diabetic ketoacidosis (DKA) is a serious and potentially life-threatening complication of diabetes mellitus in children and requires timely and structured management to prevent morbidity and mortality. Inconsistency in clinical practice and delayed recognition of complications may negatively affect patient outcomes. Evidence-based clinical nursing guidelines can improve the quality and consistency of care provided to children with DKA. This study aimed to assess the impact of an evidence-based nursing guideline on clinical outcomes among children diagnosed with diabetic ketoacidosis. A quasi-experimental study design was used, including two groups: a control group receiving routine hospital care and an intervention group receiving care based on an evidence-based nursing guideline. The guideline included structured nursing assessment, continuous monitoring of vital signs and neurological status, blood glucose monitoring, fluid balance monitoring, and early detection and management of complications. Clinical outcomes including blood glucose level, blood pH, neurological status, and duration of hospital stay were compared between the control and intervention groups.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 60 (actual)
- First submitted
- 5 Mar 2026
- Start date
- 14 May 2025
- Primary completion date
- 1 Dec 2025
- Lead sponsor
- Hawler Medical University
- NCT number
- NCT07467616
What you commit to
- Study type: Interventional
- Participants enrolled: 60
- From 14 May 2025 to the primary completion date, 1 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Children with comorbid chronic illnesses like congenital heart disease, renal failure, etc.
Other
- Recurrent admission during the same study period (only first admission considered).
Who the study is looking for
- Children age from 6-16 years old.
- Both sexes.
- Have not other critical medical condition that interfere with study.
- Diagnosed with diabetic ketoacidosis.
- Have the ability to participate and accept to participate in the study.
Age in the registry: 6 years to 16 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Raparin Pediatric Teaching Hospital Coordinator of this site? Confirm its status | Erbil | Iraq | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.